SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-025390
Filing Date
2022-05-11
Accepted
2022-05-11 07:50:13
Documents
14
Period of Report
2022-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea159744-8k_biomxinc.htm   iXBRL 8-K 33697
2 PRESS RELEASE DATED MAY 11, 2022 ea159744ex99-1_biomxinc.htm EX-99.1 66778
  Complete submission text file 0001213900-22-025390.txt   340198

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE phge-20220511.xsd EX-101.SCH 4278
4 XBRL DEFINITION FILE phge-20220511_def.xml EX-101.DEF 27711
5 XBRL LABEL FILE phge-20220511_lab.xml EX-101.LAB 38469
6 XBRL PRESENTATION FILE phge-20220511_pre.xml EX-101.PRE 26329
8 EXTRACTED XBRL INSTANCE DOCUMENT ea159744-8k_biomxinc_htm.xml XML 7457
Mailing Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 22912106
SIC: 2836 Biological Products, (No Diagnostic Substances)